openPR Logo
Press release

PREMIER Biosoft International Releases version 7.50 of AlleleID

09-19-2009 12:25 PM CET | Science & Education

Press release from: PREMIER Biosoft International

Palo Alto, California – September 15, 2009- PREMIER Biosoft International today announced the world wide release of AlleleID version 7.50. AlleleID will now enable xMAP® users to design strain differentiation assays. AlleleID employs a powerful algorithm to first align the sequences and then identify unique regions in each. The capture probes are located in these regions and then checked for multiplexing for use in bead based suspension arrays, based on Luminex's xMAP® technology.

In addition to the above, single template assays are also supported wherein oligos are designed for rapid and high-throughput SNP genotyping assays, particularly useful for population studies. It enables use of pre-designed proven oligos and designs a multiplex set compatible with them, saving costs. Included is a database of MicroPlex xTAGs (formerly known as FlexMAP TAGs) for automatic addition of appropriate tags to Allele Specific Primer Extension (ASPE) primers. Users also have the option to tag them on their own.

“AlleleID is now available for xMAP® users identifying strains. We are committed to keeping pace with their needs by constantly adding advanced and powerful features to our products,” commented Kay Brown, V.P. Business Development and Marketing.

For details, please visit: http://www.premierbiosoft.com/bacterial-identification/realtime-PCR/luminex_xMAP.html

About PREMIER Biosoft International:
Founded in 1994, the company is a group of computer scientists and molecular biologists dedicated to producing cutting-edge intuitive software for the molecular biologist. The goal of the company is to study the most recent innovations in molecular biology and translate them into software products that aid biologists. Additional information about PREMIER Biosoft International is available at http://www.PremierBiosoft.com.

Contact:
Arun Apte
PREMIER Biosoft International
650-856-2703
http://www.PremierBiosoft.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release PREMIER Biosoft International Releases version 7.50 of AlleleID here

News-ID: 96838 • Views: 1258

More Releases from PREMIER Biosoft International

PREMIER Biosoft Announces Reseller Agreement with Bruker to Advance Lipidomics a …
PREMIER Biosoft, a next generation leader in bioinformatics, and Bruker Corporation (NASDAQ: BRKR) today announced that they have entered a reselling agreement pursuant to which Bruker will co-market and resell Premier's SimLipid and SimMet, high throughput informatics tools for lipid and metabolite data analysis. Integration with Bruker's mass spectrometric workflows will enable new powerful ways for researchers to seamlessly generate, process, and analyze data. Bruker's instruments produce highly accurate broad
PREMIER Biosoft Delivers Version 2.0 of OligoEvaluator™ to Sigma Life Science
Palo Alto, California -- PREMIER Biosoft, delivered OligoEvaluator™ 2.0 to Sigma Life Science, the innovative biological products and services research business of Sigma-Aldrich. Sigma-Aldrich, a leading Life Science and High Technology company conducts operations in 37 countries and provides biochemical and organic chemical products for scientific and genomic research. The new release of OligoEvaluator™ offers analysis of physico-chemical properties of multiple DNA or RNA sequences in a single search run
PREMIER Biosoft announces the release of SimGlycan® Enterprise Edition 5.0 to s …
Palo Alto, California : PREMIER Biosoft, a next generation leader in bioinformatics, today announced the release of Enterprise Edition of SimGlycan® v. 5.0, a comprehensive high throughput tool to provide support for glycan quantitation using Thermo Scientific™ aminoxyTMT™ for MS/MS glycan data analysis workflows. Additionally, it can be used for processing of LC-MS data for peak detection, peak picking and alignment of glycans based on retention time, precursor m/z
PREMIER Biosoft announces the release of SimGlycan® v. 5.0 to provide informati …
Palo Alto, California – May 21, 2014: PREMIER Biosoft, a next generation leader in bioinformatics today announced the release of a new version of SimGlycan®, a comprehensive, high throughput tool to provide automated informatics support for LC-MS and MS/MS glycan data analysis workflows. The new version of the software facilitates processing of LC-MS and MS/MS data for peak detection, peak picking and alignment of glycans based on retention time, precursor

All 5 Releases


More Releases for Allele

What's driving Gene Editing Market ; Eminent Players – Addgene, Allele Biotech …
Gene Editing Market size is set to exceed USD 7.5 billion by 2024; according to a new research report by Global Market Insights, Inc. Increasing R&D expenditures in biotechnology sector should boost the gene editing industry growth in coming years. Due to growing incidences of rare genetic diseases, there is an increase in the demand for developing medications and vaccines utilized in treatment of these diseases. Government in developed economies
What's driving the Gene Editing Market trends? CRISPR Therapeutics, Addgene, All …
Market Study Report LLC provides a detailed overview of Gene Editing market with respect to the pivotal drivers influencing the revenue graph of this business sphere. The current trends of Gene Editing market in conjunction with the geographical landscape, demand spectrum, remuneration scale, and growth graph of this vertical have also been included in this report. Genetic technology is still evolving, and research plays an important role in exploring its potential.
Gene Editing Market 2025 | Qiagen, Sigma-Aldrich, Allele Biotech, Bio Rad, CRISP …
Global Gene Editing Market: Overview Gene editing involves the insertion, deletion, or replacement of DNA at specific sites in the genome of a cell or an organism. It is usually achieved in a laboratory environment using molecular scissors. Regulations for the security of life, well-being of plants and animals, human health, and environmental compliance will influence market players for increased focus on import, export, and commercialization of genetically modified organisms (GMOs). Get Brochure
Gene Editing Market – Notable Developments 2025 | Qiagen, Sigma-Aldrich, Allel …
Global Gene Editing Market: Overview Gene editing involves the insertion, deletion, or replacement of DNA at specific sites in the genome of a cell or an organism. It is usually achieved in a laboratory environment using molecular scissors. Regulations for the security of life, well-being of plants and animals, human health, and environmental compliance will influence market players for increased focus on import, export, and commercialization of genetically modified organisms (GMOs). Get Brochure
Gene Editing Market Research Report 2016-2024 | Key Players: Addgene, Allele Bio …
Global Gene editing market is slated to register a double-digit growth rate over the years. Rising preference for customized medicines and alternative treatments, owing to the occurrence of cancer and specific genetic disorders leads to steep rise in the global gene editing market. Rise in demand for synthetic genes leads to increased funding for genomics research, fostering the global genome editing market growth. Gene editing market growth will be stalled
Gene Editing Market – Future Adoption Overview 2025 | Sigma-Aldrich, Allele Bi …
Global Gene Editing Market: Snapshot Gene editing or genome editing is the targeted insertion or modification of cells in living organism or cells and the method has come to occupy a crucial part of biomedical researches, constantly transforming various disciplines of life sciences. Over the past few years, continuous advancements in gene-editing technologies have led to the advent of several versatile methods, which have enabled investigators to introduce a number